Skip to content
Research Article Open access CC BY 4.0

Autoimmune Hemolytic Anemia in a Patient with Chronic Myeloid Leukemia: Case Report

Benzineb Brahim, Belhadef Hanane, Chekkaf Ismahane, Mesli Naima

Asian Journal of Case Reports in Medicine and Health · pp. 21–24 · Published 14 Apr 2022

Abstract

Autoimmune hemolytic anemia is an unusual complication in chronic myeloid leukemia on Imatinib. In this case report, it had appeared in 76 year old male patient with major molecular response treated by Imatinib. During the etiological research, we had kept the drug or idiopathic causes. We had treated the patient as idiopathic autoimmune hemolytic anemia without Imatinib interruption and we had noted an improvement in anemia without losing the major molecular response.

CML AIHA imatinib

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.